Stocks and Investing
Stocks and Investing
Thu, July 21, 2022
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Vernon Bernardino Maintained (AYTU) at Strong Buy with Decreased Target to $120 on, Jul 21st, 2022
Vernon Bernardino of HC Wainwright & Co., Maintained "Aytu BioPharma, Inc." (AYTU) at Strong Buy with Decreased Target from $220 to $120 on, Jul 21st, 2022.
Vernon has made no other calls on AYTU in the last 4 months.
There is 1 other peer that has a rating on AYTU. Out of the 1 peers that are also analyzing AYTU, 0 agree with Vernon's Rating of Hold.
This is the rating of the analyst that currently disagrees with Vernon
- Jennifer Kim of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $100 on, Tuesday, May 17th, 2022
Contributing Sources